Brain-derived neurotrophic factor as a drug target for CNS disorders

By Pezet Sophie   Malcangio Marzia  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 5, 2004-10 ,pp. : 391-399

Informa Healthcare

Access to resources Recommend Favorite

Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders

By Adan R.A.H.   Vink T.  

European Neuropsychopharmacology, Vol. 11, Iss. 6, 2001-12 ,pp. : 483-490

Elsevier

Access to resources Recommend Favorite

Ligand-directed profiling: applications to target drug discovery in cancer

By Staquicini Fernanda I   Pasqualini Renata   Arap Wadih  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 51-59

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders

By Célanire Sylvain   Campo Brice  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 3, 2012-03 ,pp. : 261-280

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot Topic: Drug Discovery for CNS Disorders: From Bench to Bedside (Guest Editor: Tiago Fleming Outeiro)]

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 668-668

Bentham Science Publishers

Access to resources Recommend Favorite